News and Information

BiovitalsHF™, a Prescription Software Uses Data Science to Augment Guideline-directed Use of Heart Failure Therapies

BOSTON, March 13, 2019 /PRNewswire/ — Biofourmis, a fast-growing digital therapeutics company focused on augmenting personalized care and therapies to empower patients with complex chronic conditions, today joined the American Heart Association’s Center for Health Technology & Innovation’s (Center) Innovators Network to deliver personalized software-based intervention including dose changes, heart failure education and insights to patients with heart failure.

Read More

Biofourmis Collaborates with Brigham and Women’s Hospital to Improve Patient Home Care

Biofourmis, a Singapore-based health analytics platform, has entered into a collaboration with Brigham and Women’s Hospital in Boston, US to co-develop improvements to their proprietary analytics engine, Biovitals™ for Brigham’s Home Hospital Programme.

Read More
View More

Events

Specialized Analytics to Support Clinical Trial Endpoints

We will be sharing on the topic “Specialized Analytics to Support Clinical Trial Endpoints”

Read More

Tackling health problems using AI: Why data analytics will play a big role in healthcare.

Our COO Karen Wai will be speaking at Echelon Asia Summit 2018 on the Topic: “Tackling health problems using AI: Why data analytics will play a big role in healthcare.”

Read More

PhUSE’s first event in Singapore

Our CEO Kuldeep Singh Rajput will be speaking at PhUSE’s first event in Singapore. Drop by and say hi and let Kuldeep share with you more on our mission to change healthcare

Read More

What Our Clients Say

Whether you are a healthcare provider,
payer or pharmaceutical,
biofourmis empowers you

Get In Touch